Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam + paracetamol fixed-dose combination after impacted third molar extraction
2020-002245-42Phase 3Completed
- Sponsor
- Unither Pharmaceuticals
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute postoperative pain comparing Nefopam + paracetamol fixed-dose combination, Nefopam monotherapy and Paracetamol monotherapy (3 arms). Primary endpoint: Sum of Pain Intensity Differences at 6 hours. Started Aug 2020; status: completed.
02
Drugs
nefopamacetaminophen
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on 2020-002245-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002245-42.